DEPRESSION: The research article, Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far provides a current review of the evidence to support the use of TMS to treat individuals with treatment resistant depression. The article addresses questions about durability of treatment, maintenance therapy and efficacy of TMS treatment in special populations. For the full article click here,

ANXIETY: TMS has consistently shown to be effective in the treatment of anxiety co-morbid with depression. An example of evidence to support this in the following article: Effect of repetitive stimulation transcranial magnetic on anxiety symptoms in patients with major depression: An analysis from the THREE‐D trial. For the full article click here.

Post-Traumatic Stress Disorder (PTSD) . Over the past 10 years, increasing numbers of article support the efficacy of TMS in the treatment of PTSD. Of note, unlike depression and anxiety, the efficacy of TMS in the treatment of PTSD appears to be much more robust when TMS is coupled with concurrent Trauma-focused therapy. For a recent review of the efficacy of TMS in the treatment of PTSD see the following article: Novel Approaches for the Treatment of Post-Traumatic Stress Disorder: A Systematic Review of Non-Invasive Brain Stimulation Interventions and Insights from Clinical Trials. for the full article click here.

Some key factors that indicate a good candidate for TMS therapy are: - Treatment-Resistant Depression: Individuals who have not experienced relief from depression symptoms despite trying multiple antidepressant medications often benefit from TMS. Individuals with more severe symptoms tend to experience the most improvement. - Intolerance to Medication: Those who cannot tolerate the side effects of antidepressant medications or are unwilling to continue to try medications to treat their symptoms might consider TMS as an alternative. - Non-Invasive Preference: For individuals seeking a non-invasive treatment option, TMS provides a viable alternative without the need for anesthesia or surgery, or the somatic side effects associated with taking anti-depressant or other medications.

In general, most patients are eligible for treatment. Based on clinical experience, Transcranial Magnetic Stimulation (TMS) has proven to be effective across diverse groups, including veterans, first responders, young adults, middle-aged individuals, and elderly patients up to age 85.

Absolute contraindications:

Active seizures.

Metal implants in the head region

Wyoming TMS uses the following as a TMS Safety Review. Click here

If you have any questions about if your patient/client would be a good candidate for TMS, please call Dr. Fohrman (cell phone) at 307-998-8081

• Medicaid

• Tricare

• VA care in the community

• Blue Cross, Blue Shield

• Cigna

• UHS/OPTUM Pending

• Aetna Medicare

• Mountain Co-op

• First Choice Health

• Magellan If there is an insurance plan that you believe would be advantageous for your patients, please inform us. We will make efforts to become credentialed with that insurance provider.

-TMS Mapping Session: The standard fee for a TMS mapping session is $600

-TMS Treatment Session: The standard fee for each treatment session is between $400

For those who prefer not to use their medical insurance due to high deductible plans, or if we are not yet credentialed with their insurance provider, alternative payment options are available. Please contact us of further details.